Skip Header

Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9NS56 (TOPRS_HUMAN)

Last modified January 19, 2010. Version 71. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    E3 ubiquitin-protein ligase Topors
    EC=6.3.2.-
Alternative name(s):
    SUMO1-protein E3 ligase Topors
    Topoisomerase I-binding RING finger protein
    Topoisomerase I-binding arginine/serine-rich protein
    Tumor suppressor p53-binding protein 3
      Short name=p53-binding protein 3
      Short name=p53BP3
Gene names
Name: TOPORS
Synonyms: LUN, TP53BPL
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length1045 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Functions as an ubiquitin-protein E3 ligase and as an E3 SUMO1-protein ligase. Can both ubiquitinate and sumoylate p53. Ref.8 Ref.12

Subunit structure

Interacts with PARK7/DJ-1 By similarity. Interacts with TOP1. Interacts with p53. Interacts with the SUMO1 conjugating enzyme UBE2I. Interacts with SUMO1. Ref.1 Ref.5 Ref.7

Subcellular location

Nucleus. Note: Localizes to discrete nuclear foci which partly overlap with PML nuclear bodies. Ref.1 Ref.5 Ref.7 Ref.2 Ref.6

Tissue specificity

Expressed at highest levels in testis and at lower levels in adrenal gland, bone marrow, brain, colon, heart, kidney, liver, muscle, ovary, pancreas, placenta, prostate, skeletal muscle, skin, small intestine, spleen, stomach, testis, thymus, thyroid and uterus. Expressed in the alveolar epithelium of the lung. Expression is commonly decreased in colon adenocarcinomas and lung cancers. Ref.5 Ref.2 Ref.10

Induction

By genotoxic agents such as cisplatin and camptothecin. Ref.13

Post-translational modification

Sumoylated. Ref.12 Ref.7

Involvement in disease

Defects in TOPORS are the cause of retinitis pigmentosa type 31 (RP31) [MIM:609923]. RP leads to degeneration of retinal photoreceptor cells. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP31 inheritance is autosomal dominant. Ref.15

Sequence similarities

Contains 1 RING-type zinc finger.

Caution

Was originally (Ref.2) thought to bind to the palindromic consensus sequence 5'-TCCCAGCACTTTGGGA-3' and to regulate the transcription of numerous genes in the lung.

Alternative products

This entry describes 2 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q9NS56-1)

Also known as: LUN-1;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q9NS56-2)

Also known as: LUN-2;

The sequence of this isoform differs from the canonical sequence as follows:
     1-65: Missing.
     66-66: E → M

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 10451045E3 ubiquitin-protein ligase Topors
PRO_0000232626

Regions

Zinc finger103 – 14240RING-type
Region1 – 195195E3 ubiquitin-protein ligase activity
Region51 – 374324Required for DNA-binding
Region437 – 654218Interaction with SUMO1
Region437 – 574138Required for sumoylation and localization to discrete nuclear foci
Region456 – 882427Interaction with TOP1
Region456 – 731276Interaction with p53
Region854 – 91764Interaction with UBE2I
Compositional bias579 – 788210Arg-rich
Compositional bias854 – 89542Lys-rich

Amino acid modifications

Modified residue981Phosphoserine Ref.11 Ref.17 Ref.18 Ref.19 Ref.20
Modified residue1941Phosphoserine Ref.16
Modified residue8641Phosphoserine Ref.20
Modified residue8661Phosphoserine Ref.20
Modified residue9021Phosphoserine Ref.14
Modified residue9121Phosphoserine Ref.14
Modified residue9141Phosphoserine Ref.14
Cross-link560Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)

Natural variations

Alternative sequence1 – 6565Missing in isoform 2.
VSP_017916
Alternative sequence661E → M in isoform 2.
VSP_017917
Natural variant1541A → T: dbSNP rs17855104. Ref.4
VAR_037629
Natural variant5171E → K: dbSNP rs17855103. Ref.4
VAR_037630
Natural variant7491N → D: dbSNP rs17857515. Ref.4
VAR_037631
Natural variant8121P → R: dbSNP rs36034138.
VAR_037632

Experimental info

Mutagenesis761K → R: No effect on sumoylation. Ref.7
Mutagenesis1311W → A: Abrogates E3 ubiquitin-protein ligase activity. Ref.8
Mutagenesis3011K → R: No effect on sumoylation. Ref.7
Mutagenesis4851K → R: No effect on sumoylation. Ref.7
Mutagenesis5601K → R: Strongly reduces sumoylation. Ref.7
Mutagenesis9211K → R: No effect on sumoylation. Ref.7
Sequence conflict124 – 1252CF → K Ref.5
Sequence conflict2571N → S in AAD23379. Ref.1
Sequence conflict3081F → S in AAD23379. Ref.1
Sequence conflict9221E → G in AAD23379. Ref.1
Sequence conflict10401R → K in AAD23379. Ref.1

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 (LUN-1) [UniParc].

Last modified October 1, 2000. Version 1.
Checksum: 3DA635FDB5C83B77

FASTA1,045119,198
        10         20         30         40         50         60 
MGSQPPLGSP LSREEGEAPP PAPASEGRRR SRRVRLRGSC RHRPSFLGCR ELAASAPARP 

        70         80         90        100        110        120 
APASSEIMAS AAKEFKMDNF SPKAGTSKLQ QTVPADASPD SKCPICLDRF DNVSYLDRCL 

       130        140        150        160        170        180 
HKFCFRCVQE WSKNKAECPL CKQPFDSIFH SVRAEDDFKE YVLRPSYNGS FVTPDRRFRY 

       190        200        210        220        230        240 
RTTLTRERNA SVYSPSGPVN RRTTTPPDSG VLFEGLGIST RPRDVEIPQF MRQIAVRRPT 

       250        260        270        280        290        300 
TADERSLRKI QEQDIINFRR TLYRAGARVR NIEDGGRYRD ISAEFFRRNP ACLHRLVPWL 

       310        320        330        340        350        360 
KRELTVLFGA HGSLVNIVQH IIMSNVTRYD LESQAFVSDL RPFLLNRTEH FIHEFISFAR 

       370        380        390        400        410        420 
SPFNMAAFDQ HANYDCPAPS YEEGSHSDSS VITISPDEAE TQELDINVAT VSQAPWDDET 

       430        440        450        460        470        480 
PGPSYSSSEQ VHVTMSSLLN TSDSSDEELV TGGATSQIQG VQTNDDLNND SDDSSDNCVI 

       490        500        510        520        530        540 
VGFVKPLAER TPELVELSSD SEDLGSYEKM ETVKTQEQEQ SYSSGDSDVS RCSSPHSVLG 

       550        560        570        580        590        600 
KDEQINKGHC DSSTRIKSKK EEKRSTSLSS PRNLNSSVRG DRVYSPYNHR HRKRGRSRSS 

       610        620        630        640        650        660 
DSRSQSRSGH DQKNHRKHHG KKRMKSKRSR SRESSRPRGR RDKKRSRTRD SSWSRRSQTL 

       670        680        690        700        710        720 
SLSSESTSRS RSRSSDHGKR RSRSRNRDRY YLRNNYGSRY KWEYTYYSRN KDRDGYESSY 

       730        740        750        760        770        780 
RRRTLSRAHY SRQSSSPEFR VQSFSERTNA RKKNNHSERK YYYYERHRSR SLSSNRSRTA 

       790        800        810        820        830        840 
STGTDRVRNE KPGGKRKYKT RHLEGTNEVA QPSREFASKA KDSHYQKSSS KLDGNYKNES 

       850        860        870        880        890        900 
DTFSDSRSSD RETKHKRRKR KTRSLSVEIV YEGKATDTTK HHKKKKKKHK KKHKKHHGDN 

       910        920        930        940        950        960 
ASRSPVVITI DSDSDKDSEV KEDTECDNSG PQDPLQNEFL APSLEPFETK DVVTIEAEFG 

       970        980        990       1000       1010       1020 
VLDKECDIAT LSNNLNNANK TVDNIPPLAA SVEQTLDVRE ESTFVSDLEN QPSNIVSLQT 

      1030       1040 
EPSRQLPSPR TSLMSVCLGR DCDMS 

« Hide

Isoform 2 (LUN-2).

Checksum: 85E2A39A2978B20E
Show »

FASTA980112,344

References

« Hide 'large scale' references
[1]"Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein."
Haluska P. Jr., Saleem A., Rasheed Z., Ahmed F., Su E.W., Liu L.F., Rubin E.H.
Nucleic Acids Res. 27:2538-2544(1999) [PubMed: 10352183] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH TOP1, SUBCELLULAR LOCATION.
[2]"Cloning and characterization of LUN, a novel RING-finger protein that is highly expressed in lung and specifically binds to a palindromic sequence."
Chu D., Kakazu N., Gorrin-Rivas M.J., Lu H.P., Kawata M., Abe T., Ueda K., Adachi Y.
J. Biol. Chem. 276:14004-14013(2001) [PubMed: 11278651] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), PUTATIVE DNA-BINDING, SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
Tissue: Lung.
[3]"DNA sequence and analysis of human chromosome 9."
Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. expand/collapse author list , Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., Dunham I.
Nature 429:369-374(2004) [PubMed: 15164053] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[4]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), VARIANTS THR-154; LYS-517 AND ASP-749.
Tissue: Placenta.
[5]"Identification of a novel gene encoding a p53-associated protein."
Zhou R., Wen H., Ao S.-Z.
Gene 235:93-101(1999) [PubMed: 10415337] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 51-1045 (ISOFORM 1), INTERACTION WITH TP53, SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
[6]"The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies."
Rasheed Z.A., Saleem A., Ravee Y., Pandolfi P.P., Rubin E.H.
Exp. Cell Res. 277:152-160(2002) [PubMed: 12083797] [Abstract]
Cited for: SUBCELLULAR LOCATION.
[7]"The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation."
Weger S., Hammer E., Engstler M.
Exp. Cell Res. 290:13-27(2003) [PubMed: 14516784] [Abstract]
Cited for: INTERACTION WITH SUMO1 AND UBE2I, SUBCELLULAR LOCATION, SUMOYLATION, MUTAGENESIS OF LYS-76; LYS-301; LYS-485; LYS-560 AND LYS-921.
[8]"Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53."
Rajendra R., Malegaonkar D., Pungaliya P., Marshall H., Rasheed Z., Brownell J., Liu L.F., Lutzker S., Saleem A., Rubin E.H.
J. Biol. Chem. 279:36440-36444(2004) [PubMed: 15247280] [Abstract]
Cited for: FUNCTION, MUTAGENESIS OF TRP-131.
[9]"Expression of LUN gene that encodes a novel RING finger protein is correlated with development and progression of non-small cell lung cancer."
Oyanagi H., Takenaka K., Ishikawa S., Kawano Y., Adachi Y., Ueda K., Wada H., Tanaka F.
Lung Cancer 46:21-28(2004) [PubMed: 15364129] [Abstract]
Cited for: REDUCED EXPRESSION IN LUNG CANCERS.
[10]"The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor."
Saleem A., Dutta J., Malegaonkar D., Rasheed F., Rasheed Z., Rajendra R., Marshall H., Luo M., Li H., Rubin E.H.
Oncogene 23:5293-5300(2004) [PubMed: 15107820] [Abstract]
Cited for: TISSUE SPECIFICITY, REDUCED EXPRESSION IN COLON CANCERS.
[11]"Large-scale characterization of HeLa cell nuclear phosphoproteins."
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, MASS SPECTROMETRY.
Tissue: Epithelium.
[12]"Topors acts as a SUMO-1 E3 ligase for p53 in vitro and in vivo."
Weger S., Hammer E., Heilbronn R.
FEBS Lett. 579:5007-5012(2005) [PubMed: 16122737] [Abstract]
Cited for: FUNCTION, SUMOYLATION.
[13]"Topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage."
Lin L., Ozaki T., Takada Y., Kageyama H., Nakamura Y., Hata A., Zhang J.H., Simonds W.F., Nakagawara A., Koseki H.
Oncogene 24:3385-3396(2005) [PubMed: 15735665] [Abstract]
Cited for: INDUCTION.
[14]"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.
Cell 127:635-648(2006) [PubMed: 17081983] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-902; SER-912 AND SER-914, MASS SPECTROMETRY.
Tissue: Epithelium.
[15]"Mutations in TOPORS cause autosomal dominant retinitis pigmentosa with perivascular retinal pigment epithelium atrophy."
Chakarova C.F., Papaioannou M.G., Khanna H., Lopez I., Waseem N., Shah A., Theis T., Friedman J., Maubaret C., Bujakowska K., Veraitch B., El-Aziz M.M.A., Prescott de Q., Parapuram S.K., Bickmore W.A., Munro P.M.G., Gal A., Hamel C.P. expand/collapse author list , Marigo V., Ponting C.P., Wissinger B., Zrenner E., Matter K., Swaroop A., Koenekoop R.K., Bhattacharya S.S.
Am. J. Hum. Genet. 81:1098-1103(2007) [PubMed: 17924349] [Abstract]
Cited for: INVOLVEMENT IN RP31.
[16]"Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis."
Wang B., Malik R., Nigg E.A., Korner R.
Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, MASS SPECTROMETRY.
[17]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, MASS SPECTROMETRY.
[18]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, MASS SPECTROMETRY.
[19]"Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.
Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98, MASS SPECTROMETRY.
[20]"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98; SER-864 AND SER-866, MASS SPECTROMETRY.
Tissue: T-cell.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AF098300 mRNA. Translation: AAD23379.1.
AB045732 mRNA. Translation: BAB03714.1.
AB045733 mRNA. Translation: BAB03715.1.
AL353671 Genomic DNA. Translation: CAH71253.1.
AL353671 Genomic DNA. Translation: CAH71254.1.
BC060884 mRNA. Translation: AAH60884.1.
U82939 mRNA. Translation: AAC98530.1. Different initiation.
IPIIPI00396077.
IPI00643426.
RefSeqNP_005793.2.
UniGeneHs.589962

3D structure databases

SMRQ9NS56. Positions 99-163.
ModBaseSearch...

Protein-protein interaction databases

STRINGQ9NS56.

PTM databases

PhosphoSiteQ9NS56.

Proteomic databases

PRIDEQ9NS56.

Genome annotation databases

EnsemblENST00000360538; ENSP00000353735; ENSG00000197579; Homo sapiens. [Genome view]
GeneID10210.
KEGGhsa:10210.
UCSCuc003zrb.1. human.
uc003zrc.1. human.

Organism-specific databases

CTD10210.
GeneCardsGC09M032530.
H-InvDBHIX0034742.
HGNCHGNC:21653. TOPORS.
MIM609507. gene.
609923. phenotype.
Orphanet791. Retinitis pigmentosa.
PharmGKBPA134979531.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG18391.
HOGENOMHBG283067.
HOVERGENQ9NS56.
InParanoidQ9NS56.
OMADIINFRR.
OrthoDBEOG9QNQGF.
PhylomeDBQ9NS56.

Gene expression databases

ArrayExpressQ9NS56.
BgeeQ9NS56.
CleanExHS_TOPORS.
GenevestigatorQ9NS56.
GermOnlineENSG00000197579. Homo sapiens.

Family and domain databases

InterProIPR018957. Znf_C3HC4_RING-type.
IPR001841. Znf_RING.
IPR017907. Znf_RING_CS.
[Graphical view]
PfamPF00097. zf-C3HC4. 1 hit.
[Graphical view]
SMARTSM00184. RING. 1 hit.
[Graphical view]
PROSITEPS00518. ZF_RING_1. 1 hit.
PS50089. ZF_RING_2. 1 hit.
[Graphical view]
ProtoNetSearch...

Other Resources

NextBio38656.
SOURCESearch...

Entry information

Entry nameTOPRS_HUMAN
AccessionPrimary (citable) accession number: Q9NS56
Secondary accession number(s): O43273 expand/collapse secondary AC list , Q6P987, Q9NS55, Q9UNR9
Entry history
Integrated into UniProtKB/Swiss-Prot: April 18, 2006
Last sequence update: October 1, 2000
Last modified: January 19, 2010
This is version 71 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 9

Human chromosome 9: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Cross-references · Entry information · Relevant documents